Effect of noradrenergic system on the anxiolytic-like effect of DOI -5-HT2A and 2C agonists- in the four-plate test-
Send a publication request
close

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.




- Categories : Miscellaneous research domains , Publications - ID: 67

Authors
F. Massé, M. Hascoët, E. Dailly, M. Bourin.


Lab
Faculté de Médecine, Neurobiologie de l’anxiété et de la dépression, Nantes, France.

Journal
Psychopharmacology

Abstract
Rationale: Selective serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors demonstrated an anxiolytic-like effect in the four-plate test (FPT). (+/_)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI; a 5-HT2A receptor agonist) also possessed strong anxiolytic-like effect in the same test. A 5-HT2A mechanism seems to be implicated in the mechanism of action of both antidepressants and DOI in this test. On the other hand, the _-adrenergic ligands have also demonstrated an activity in other models of anxiety. A previous study demonstrated that the _2-adrenoceptor agonists abolished the anxiolytic-like effect of antidepressants.  Objectives: The aim of the present study was to evaluate the role of noradrenergic system on the regulation of 5-HT2 receptors implicated in the DOI anxiolytic-like activity in the FPT. Methods: First, the effect of noradrenergic and serotonergic lesions on DOI anxiolytic-like activity was studied in the FPT. Second, the effect of co-administration of _-adrenoceptor ligands and DOI was evaluated in the same test. Results: The noradrenergic and serotonergic lesions had no effect on DOI (1 mg/kg) anti-punishment activity in the FPT. Adrafinil 0.25 and 4 mg/kg (an _1-adrenoceptor agonist), prazosin 0.5 and 2 mg/kg (an _1-adrenoceptor antagonist) and idazoxan 1 and 4 mg/kg (an _2-adrenoceptor antagonist) did not modify the activity of DOI. Clonidine 0.06 mg/kg, guanabenz 0.125 and 0.5 mg/kg (two _2-adrenoceptor agonists) and guanfacine 0.06 and 0.125 mg/kg (a specific _2A-adrenoceptor agonist) completely abolished DOI-induced increase in punished passages. Conclusion: These results indicate that the DOI seems to act on the 5-HT2 receptors post-synaptically located. The effect of DOI is regulated by the _2-adrenoceptors.

BIOSEB Instruments Used:
Aron Test or Four Plates Test (LE830)

Share this content